Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)

PHASE3CompletedINTERVENTIONAL

Enrollment

313

Participants

Timeline

Start Date

August 11, 1994

Primary Completion Date

September 16, 1994

Study Completion Date

September 16, 1994

Conditions

Rhinitis, Allergic, Seasonal

Interventions

DRUG

Mometasone furoate

Mometasone furoate nasal spray, 200 mg once daily

DRUG

Fluticasone propionate

Fluticasone propionate nasal spray, 200 mg once daily

DRUG

Mometasone furoate placebo

Mometasone furoate placebo matching nasal spray, once daily

DRUG

Fluticasone propionate placebo

Fluticasone propionate placebo matching nasal spray, once daily

All Listed Sponsors

lead

Organon and Co

INDUSTRY